H19 lncRNA: Roles in tumorigenesis

被引：197
作者：
Ghafouri-Fard, Soudeh [1 ]
Esmaeili, Mohammadhosein [2 ]
Taheri, Mohammad [3 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Urol & Nephrol Res Ctr, Tehran, Iran
[2] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Urogenital Stem Cell Res Ctr, Tehran, Iran
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2020年 / 123卷
关键词：
H19; lncRNA; Cancer; Biomarker; NONCODING RNA H19; EPITHELIAL-MESENCHYMAL TRANSITION; PROMOTES TUMOR-GROWTH; BREAST-CANCER CELLS; POOR-PROGNOSIS; COLORECTAL-CANCER; UP-REGULATION; DIAGNOSTIC BIOMARKER; DOWN-REGULATION; BLADDER-CANCER;
D O I：
10.1016/j.biopha.2019.109774
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
H19 is a long non-coding RNA [lncRNA] which was firstly described as an oncofetal transcript. The imprinted gene is normally expressed from the maternal allele. However, this pattern of imprinting is dysregulated in several cancers leading to aberrant up-regulation of H19 in malignant tissues. Several studies have utilized this aberrant expression pattern to find specific biomarkers for detection of cancer in tumoral tissues or peripheral blood. Moreover, single nucleotide polymorphisms within H19 have been associated with risk of oral squamous cell carcinoma, hepatocellular carcinoma, breast cancer, bladder cancer, gastric cancer and colorectal cancer. Taken together, H19 is regarded as a biomarker for cancer and a putative therapeutic target in these human disorders.
引用
收藏
页数：10
相关论文
共 94 条
  • [1] The product of the imprinted H19 gene is an oncofetal RNA
    Ariel, I
    Ayesh, S
    Perlman, EJ
    Pizov, G
    Tanos, V
    Schneider, T
    Erdmann, VA
    Podeh, D
    Komitowski, D
    Quasem, AS
    deGroot, N
    Hochberg, A
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1997, 50 (01): : 34 - 44
  • [2] Ariel I, 2000, AM J MED GENET, V91, P46, DOI 10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO
  • [3] 2-I
  • [4] Possible physiological role of H19 RNA
    Ayesh, S
    Matouk, I
    Schneider, T
    Ohana, P
    Laster, M
    Al-Sharef, W
    de-Groot, N
    Hochberg, A
    [J]. MOLECULAR CARCINOGENESIS, 2002, 35 (02) : 63 - 74
  • [5] H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer
    Chen, J. S.
    Wang, Y. F.
    Zhang, X. Q.
    Lv, J. M.
    Li, Y.
    Liu, X. X.
    Xu, T. P.
    [J]. NEOPLASMA, 2016, 63 (02) : 223 - 230
  • [6] The long non-coding RNA H19 induces hypoxia/reoxygenation injury by up-regulating autophagy in the hepatoma carcinoma cells
    Cui, Chao
    Li, Zhiyu
    Wu, Dequan
    [J]. BIOLOGICAL RESEARCH, 2019, 52 (1)
  • [7] Cui HM, 2002, CANCER RES, V62, P6442
  • [8] Dai N, 2017, ELIFE, V6, DOI [10.7554/eLife.27155.001, 10.7554/eLife.27155]
  • [9] LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling
    Ding, Dayong
    Li, Changfeng
    Zhao, Tiancheng
    Li, Dandan
    Yang, Lei
    Zhang, Bin
    [J]. MOLECULES AND CELLS, 2018, 41 (05) : 423 - 435
  • [10] Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome
    Engel, JR
    Smallwood, A
    Harper, A
    Higgins, MJ
    Oshimura, M
    Reik, O
    Schofield, PN
    Maher, ER
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (12) : 921 - 926
12345678910